发明名称 COMBINATION THERAPY FOR TREATING DIABETES AND CONDITION RELATED TO DIABETES, AND TREATING CONDITION TO BE IMPROVED WITH INCREASE IN BLOOD GLP-1 LEVEL
摘要 <P>PROBLEM TO BE SOLVED: To provide a composition and a method for treating or preventing diabetes and a condition related to diabetes, and for increasing blood GLP-1 level in mammals. <P>SOLUTION: There is provided a combination of a specific amount of GPR 119 agonist and a specific amount of DPP-IV inhibitor. The combination has a better effect on a decrease in a blood glucose level or an increase in blood GLP-1 level in a subject than in the case of using only a specific amount of GPR 119 agonist or only a specific amount of DPP-IV inhibitor. The combination is therefore provided for treating or preventing diabetes and a condition related to diabetes, and for a condition to be improved with an increase in blood GLP-1 level. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012017330(A) 申请公布日期 2012.01.26
申请号 JP20110172381 申请日期 2011.08.05
申请人 ARENA PHARMACEUTICALS INC 发明人 CHU ZHI-LIANG;LEONARD JAMES N;AL-SHAMMA HUSSIEN A;JONES ROBERT M
分类号 A61K45/06;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P5/48;A61P9/10;A61P9/12;A61P13/12;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/12;A61P43/00;C12Q1/02;G01N33/15;G01N33/50 主分类号 A61K45/06
代理机构 代理人
主权项
地址